Development of androgen resistance in prostatic cancer.
Isaacs
J T
JT
James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland 21205.
Schulze
H
H
Coffey
D S
DS
D000726:Androgen Antagonists / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists